Raymond James analyst Lawrence Keusch upgraded Becton Dickinson to Strong Buy from Outperform and increased its price target to $226 from $210 and believes it should be a core holding based an an above average outlook for 5-6% organic growth and mid-teens earnings increases with further potential upside. The analyst views the C.R. Bard acquisition as a sold strategic fit with an accelerating growth profile given its deep R&D pipeline and sizeable addressable market opportunities. Post close, he sees strong free cash flow generation of $10B from 2018-2020, allowing the company to rapidly deleverage to 3x in 2020 from 4.7x.